Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Chris Brooks, Nina Shaafi Kabiri, Farzad Mortazavi, Sanford Auerbach, Paolo Bonato, Michael Kelley Erb, Matt Czech, Dan Karlin, Tim Rolph, Jaspreet Bhangu & Kevin Thomas. (2020) Variations in rest-activity rhythm are associated with clinically measured disease severity in Parkinson’s disease. Chronobiology International 37:5, pages 699-711.
Read now
Read now
Articles from other publishers (17)
Mireille Tabikh, Charbel Chahla, Nathalie Okdeh, Herve Kovacic, Jean-Marc Sabatier & Ziad Fajloun. (2022) Parkinson disease: Protective role and function of neuropeptides. Peptides 151, pages 170713.
Crossref
Crossref
Yuan Yuan, Yimeng Zhang, Yueyang Cheng, Yue Hou, Zhaoyang Huang, Jinghong Ma, Ning Li & Shuqin Zhan. (2022) Cerebrospinal Fluid TNF-α and Orexin in Patients With Parkinson's Disease and Rapid Eye Movement Sleep Behavior Disorder. Frontiers in Neurology 13.
Crossref
Crossref
Sachin Kumar, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Ahmed Al-Harassi, Mohammed M. Abdel-Daim & Simona Bungau. (2021) Exploring the Role of Orexinergic Neurons in Parkinson’s Disease. Neurotoxicity Research 39:6, pages 2141-2153.
Crossref
Crossref
Lynn Marie Trotti, Donald L. Bliwise, Glenda L. Keating, David B. Rye & William T. Hu. (2021) Cerebrospinal Fluid Hypocretin and Nightmares in Dementia Syndromes. Dementia and Geriatric Cognitive Disorders Extra 11:1, pages 19-25.
Crossref
Crossref
Milos Stanojlovic, Jean Pierre Pallais & Catherine M. Kotz. (2021) Inhibition of Orexin/Hypocretin Neurons Ameliorates Elevated Physical Activity and Energy Expenditure in the A53T Mouse Model of Parkinson’s Disease. International Journal of Molecular Sciences 22:2, pages 795.
Crossref
Crossref
Shen Huang, Zhenxiang Zhao, Jianjun Ma, Shiyu Hu, Linyi Li, Zhidong Wang, Wenhua Sun, Xiaoxue Shi, Mingjian Li & Jinhua Zheng. (2021) Increased plasma orexin-A concentrations are associated with the non-motor symptoms in Parkinson’s disease patients. Neuroscience Letters 741, pages 135480.
Crossref
Crossref
Cui Liu, Yan Xue, Mei-Fang Liu, Ying Wang & Lei Chen. (2020) Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potential. Neurochemistry International 138, pages 104754.
Crossref
Crossref
Elena Antelmi, Fabio Pizza, Christian Franceschini, Raffaele Ferri & Giuseppe Plazzi. (2020) REM sleep behavior disorder in narcolepsy: A secondary form or an intrinsic feature?. Sleep Medicine Reviews 50, pages 101254.
Crossref
Crossref
Luiz M. Oliveira, Elisandra Henrique, Isabella B. Bustelli, Nelson F.C. Netto, Thiago S. Moreira, Ana C. Takakura & Ariadiny L. Caetano. (2020) Depletion of hypothalamic hypocretin/orexin neurons correlates with impaired memory in a Parkinson's disease animal model. Experimental Neurology 323, pages 113110.
Crossref
Crossref
Milos Stanojlovic, Jean Pierre Pallais, Michael K. Lee & Catherine M. Kotz. (2019) Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson’s disease. Molecular Brain 12:1.
Crossref
Crossref
Milos Stanojlovic, Jean Pierre Pallais YllescasJrJr, Aarthi Vijayakumar & Catherine Kotz. (2019) Early Sociability and Social Memory Impairment in the A53T Mouse Model of Parkinson’s Disease Are Ameliorated by Chemogenetic Modulation of Orexin Neuron Activity. Molecular Neurobiology 56:12, pages 8435-8450.
Crossref
Crossref
Elena Antelmi, Fabio Pizza, Vincenzo Donadio, Marco Filardi, Yuri L. Sosero, Alex Incensi, Stefano Vandi, Monica Moresco, Raffaele Ferri, Sara Marelli, Luigi Ferini‐Strambi, Rocco Liguori & Giuseppe Plazzi. (2019) Biomarkers for REM sleep behavior disorder in idiopathic and narcoleptic patients. Annals of Clinical and Translational Neurology 6:9, pages 1872-1876.
Crossref
Crossref
Milos Stanojlovic, Jean Pierre Pallais & Catherine M. Kotz. (2019) Chemogenetic Modulation of Orexin Neurons Reverses Changes in Anxiety and Locomotor Activity in the A53T Mouse Model of Parkinson’s Disease. Frontiers in Neuroscience 13.
Crossref
Crossref
Stuart J. McCarter, Erik K. St. Louis & Bradley F. Boeve. 2017. Sleep Disorders Medicine. Sleep Disorders Medicine
1069
1086
.
Julie Anja Engelhard Christensen, Poul Jennum, Henriette Koch, Rune Frandsen, Marielle Zoetmulder, Lars Arvastson, Søren Rahn Christensen & Helge Bjarrup Dissing Sorensen. (2016) Sleep stability and transitions in patients with idiopathic REM sleep behavior disorder and patients with Parkinson’s disease. Clinical Neurophysiology 127:1, pages 537-543.
Crossref
Crossref
Todd J. Swick & William G. Ondo. 2016. Dopamine and Sleep. Dopamine and Sleep
115
146
.
Félix J. Jiménez-Jiménez, Hortensia Alonso-Navarro, Elena GarcÃa-MartÃn & José A. G. Agúndez. (2014) Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease. Frontiers in Cellular Neuroscience 8.
Crossref
Crossref